carvedilol has been researched along with bevantolol in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Hamada, M; Hara, Y; Matsunaka, T; Nakata, S; Ogimoto, A; Ohtsuka, T; Saeki, H; Shigematsu, Y; Suzuki, J | 1 |
Hamada, M; Hara, Y; Higaki, J; Ogimoto, A; Ohtsuka, T; Shigematsu, Y | 1 |
Hara, Y; Higaki, J; Inoue, K; Nakata, S; Ogimoto, A; Ohtsuka, T; Shigematsu, Y | 1 |
2 trial(s) available for carvedilol and bevantolol
Article | Year |
---|---|
Use of thallium-201 myocardial scintigraphy for the prediction of the response to beta-blocker therapy in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Forecasting; Heart; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Multivariate Analysis; Probability; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Thallium Radioisotopes; Treatment Outcome | 2002 |
Effect of beta-blockers on insulin resistance in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Echocardiography; Female; Hemodynamics; Humans; Insulin Resistance; Male; Metoprolol; Middle Aged; Osmolar Concentration; Propanolamines; Tumor Necrosis Factor-alpha | 2003 |
4 other study(ies) available for carvedilol and bevantolol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Effect of beta-blocker therapy on myocardial perfusion defects in thallium-201 scintigraphy in patients with dilated cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Coronary Circulation; Echocardiography; Female; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Natriuretic Peptides; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Thallium Radioisotopes; Ventricular Function, Left | 2005 |